Urology Lasers Market Size - By Type (Holmium Laser System, Diode Laser System, Thulium Laser System), By Application (Benign Prostatic Hyperplasia {BPH}, Urolithiasis, Non-muscle-invasive Bladder Cancer {NMIBC}) By End-use– Global Forecast, 2023-2032

Urology Lasers Market Size

Urology Lasers Market size was valued at USD 1.2 billion in 2022 and is estimated to account for USD 2 billion by 2032. Urology lasers are advanced medical devices that utilize focused laser beams to diagnose and treat numerous conditions associated with the urinary tract.
 

These lasers offer precision and minimal tissue damage during endoscopy, enabling visualization and treatment of kidney stones, bladder tumors, and urethral strictures. Also, these systems are particularly effective in breaking down kidney stones through lithotripsy, fragmenting them into smaller pieces for easy removal. Urology lasers are also used for tissue ablation, coagulation, and vaporization, aiding in the removal of abnormal tissue growths, and treating benign prostatic hyperplasia (BPH) for improved urinary flow. Moreover, urology lasers offer several benefits including reduced bleeding, shorter recovery period, and minimal post-operative complications will boost customer preference thereby, accelerating product demand.
 

The global burden of chronic diseases including diabetes poses a significant risk factor for various urological complications such as diabetic nephropathy, diabetic cystopathy, urinary tract infections (UTIs), urological stones, erectile dysfunction, and urethral strictures lead to increasing urological procedures. For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas report, in 2021, more than 10.5% of the adult population aged 20-79 years have diabetes and almost half of them are unaware of their condition. Additionally, the International Diabetes Federation (IDF) projected that approximately 783 million adults, or 1 in 8 individuals, will be living with diabetes by 2045.

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the urology lasers market. During the early stages of the pandemic, healthcare systems worldwide faced challenges due to overwhelmed hospitals, diverted resources, and restrictions on elective procedures. Non-urgent and elective surgeries, including many urology laser procedures, were postponed, or cancelled to prioritize COVID-19 patients and conserve medical resources. As, hospitals and healthcare facilities adapted to the new challenges, implementing safety measures, and creating separate treatment zones. Telemedicine and remote patient monitoring gained prominence, allowing for continued management of urological conditions. As vaccination efforts increased and COVID-19 cases declined, the resumption of elective procedures addressed the pent-up demand for urology laser treatments.
 

Urology Lasers Market Trends

Technological advancements have led to the development of more sophisticated and precise medical laser systems, enabling healthcare professionals to perform urological procedures with improved accuracy and efficiency. For instance, Boston Scientific recently announced the U.S. FDA clearance for the LithoVue single-use digital flexible ureteroscope. This innovative device provides high-resolution digital images and navigation capabilities for better precision, speed, and cost-effectiveness. Such product launches with advanced technologies offered market expansion capabilities to the firm. Additionally, the rising preference for minimally invasive treatments among patients will impel the demand for urology lasers, as they offer reduced post-operative discomfort, shorter recovery times, and improved patient outcomes compared to traditional surgical methods.
 

Urology Lasers Market Analysis

The urology lasers market by type is categorized into holmium laser system, diode laser system, thulium laser system, and others. The holmium laser system segment garnered USD 411.5 million revenue size in the year 2022. These lasers cater a wide range of applications in treating kidney stones, bladder tumors, urethral strictures, and benign prostatic hyperplasia (BPH). Holmium lasers are particularly effective in fragmenting kidney stones, reducing patient discomfort, and minimizing the need for invasive procedures thereby, surging patient preference.
 

For instance, the Lumenis Pulse 120H holmium laser system integrated with MOSES technology from Boston Scientific Corporation represents a groundbreaking and patent-protected pulse delivery innovation. This advanced technology significantly enhances energy transmission, leading to highly efficient lithotripsy treatments compared to conventional holmium pulse systems. With ongoing technological advancements, these lasers offer enhanced efficiency and control during procedures.
 

On the basis of application, the urology lasers market is segmented as benign prostatic hyperplasia (BPH), urolithiasis, non-muscle-invasive bladder cancer (NMIBC), and others. The BPH segment accounted for over 38% market share in the year 2022. Benign prostatic hyperplasia is a prevalent condition affecting aging males. For instance, as per the National Institutes of Health, the prevalence of BPH experiences a notable increase after the age of 40, with a range of 8% to 60% observed among individuals by the time they reach 90 years of age, leading to increasing demand for effective treatment options.
 

Moreover, urology lasers offer a minimally invasive alternative to traditional surgeries, providing reduced discomfort and faster recovery. Their efficacy and precision in treating BPH by accurately ablating excess prostate tissue while preserving healthy tissue will contribute to improved patient outcomes and satisfaction. Growing awareness and acceptance of urology lasers in BPH treatment, along with technological advancements will spur the industry gains.
 

Based on end-use, the urology lasers market is segmented into hospitals, specialty clinics, and others. The hospitals segment is predicted to witness the highest progression at 5.5% CAGR by 2032. The growing healthcare infrastructure, integration of advanced technologies, and presence of skilled healthcare professionals for complex urological procedures. Furthermore, high patient volume among facilities and favorable reimbursement policies for urological procedures will drive the adoption rate of the business.  
 

U.S. urology lasers market accounted for USD 414.5 million market size in 2022. Advanced healthcare infrastructure equipped with state-of-the-art hospitals and a strong presence of skilled professionals for urological treatments in the U.S. is poised to stimulate industry revenue expansion potential. The rising prevalence of urological conditions, combined with high healthcare spending and favorable reimbursement policies will foster the demand for urology lasers. Additionally, a well-informed population and growing awareness of the benefits of urology lasers.
 

Urology Lasers Market Share

Some of the eminent market participants operating in the urology lasers market include:

• Boston Scientific Corporation
• Olympus Corporation
• Lumenis Ltd.
• Cook Medical
• Richard Wolf GmbH
• Stryker Corporation,
• KARL STORZ SE & Co. KG
• Quanta System S.p.A
• Biolitec AG
• El.En. S.p.A.
• ForTec Medical, Inc.
• Medtronic plc
• and Ethicon Inc.
• (Johnson & Johnson) 

Urology Lasers Industry News:

• In February 2023, Boston Scientific recently received clearance certificate for its LithoVue single-use digital flexible ureteroscope from the U.S. FDA. This innovative device provides high-resolution digital images and navigation capabilities for better precision, speed, and cost-effectiveness. Such product launches with advanced technologies offer market expansion capabilities to the firm.
   
• In March 2021, Boston Scientific Corporation acquired surgical business of Lumenis Ltd. Through this acquisition Boston Scientific Corporation strengthened its laser systems, fibers, and accessories portfolio that are utilized for otolaryngology and urology procedures.
   

Urology lasers devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type (USD Million & Units)

• Holmium laser system
• Diode laser system
• Thulium laser system
• Others

By Application (USD Million)

• Benign prostatic hyperplasia (BPH)
• Urolithiasis
• Non-muscle-invasive bladder cancer (NMIBC)
• Others

By End-use (USD Million)

• Hospitals
• Specialty clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey